20271-33-4

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 5-AMINO-1-BENZYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE is used as a building block for the synthesis of various pharmaceutical drugs and biologically active molecules. Its unique structure and functional groups make it a valuable component in the development of new drugs for the treatment of various diseases and medical conditions.
Used in Organic Synthesis:
ETHYL 5-AMINO-1-BENZYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE is used as a key intermediate in organic synthesis. Its versatile structure allows for the formation of a wide range of chemical compounds, making it a valuable tool in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
ETHYL 5-AMINO-1-BENZYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE is used as a starting material in medicinal chemistry for the development of new drugs and therapeutic agents. Its potential applications in drug discovery make it an important compound in the field of medicinal chemistry.
Used in Research and Development:
ETHYL 5-AMINO-1-BENZYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLATE is used in research and development for the exploration of its potential applications in various fields, including pharmaceuticals, organic synthesis, and medicinal chemistry. Its unique properties and reactivity make it an interesting subject for scientific investigation and innovation.

InChI:InChI=1/C12H14N4O2/c1-2-18-12(17)10-11(13)16(15-14-10)8-9-6-4-3-5-7-9/h3-7H,2,8,13H2,1H3

Upstream product

• 64-17-5 ethanol 
• 141-52-6 sodium ethanolate 
• 105-56-6 ethyl 2-cyanoacetate 
• 622-79-7 benzyl azide 
• 100-39-0 benzyl bromide 

Downstream Products

• 4342-08-9 4-amino-3-benzyl-1,2,3-triazole-5-carboxamide 
• 16975-91-0 5-Amino-1-benzyl-1,2,3-triazole-4-carboxylic Acid Hydrazide 
• 127572-30-9 5-Amino-1-benzyl-1H-[1,2,3]triazole-4-carboxylic acid [2-(3,4-dimethoxy-phenyl)-ethyl]-amide 
• 94018-43-6 ethyl 5-acetylamino-1-phenylmethyl-1H-1,2,3-triazole-4-carboxylate 
• 127572-21-8 1-Benzyl-5-ethoxymethyleneamino-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester 
• 112881-60-4 5-azido-1-benzyl-4-ethoxycarbonyl-1,2,3-triazole 
• 36540-25-7 1-benzyl-5-amino-1,2,3-triazole-4-carbonyl azide 
• 103742-40-1 1-benzyl-5-amino-1,2,3-triazole-4-carbamic acid methyl ester 
• 36540-27-9 1-benzyl-4,5-diamino-1,2,3-triazole 
• 112881-63-7 3,4-dihydro-3-benzyl-5-cyano-9H-bis<1,2,3>triazolo<1,5-a:4',5'-d>pyrimidin-9-one 
• 112881-62-6 3,4-dihydro-3-benzyl-5-phenyl-9H-bis<1,2,3>triazolo<1,5-a:4',5'-d>pyrimidin-9-one 
• 112881-66-0 3,7-dihydro-3-benzyl-7-methyl-5-phenyl-9H-bis<1,2,3>triazolo<1,5-a:4',5'-d>pyrimidin-9-one 
• 94018-46-9 5,6-dimethyl-3-phenylmethyl-3H-1,2,3-triazolo<4,5-d>pyrimidin-7(6)H-one 
• 94018-12-9 N,6-diethyl-5-methyl-3-phenylmethyl-3H-1,2,3-triazolo<4,5-d>pyrimidin-7(6)H-imine 

Relevant academic research and scientific papers

Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: Beyond the Dimroth rearrangement

The 5-amino-1,2,3-triazole-4-carboxylic acid is a suitable molecule for the preparation of collections of peptidomimetics or biologically active compounds based on the triazole scaffold. However, its chemistry may be influenced by the possibility of under

Angiotensin II receptor antagonists

Compounds are disclosed having the formula: STR1 wherein the substituents are defined herein. The compounds of the invention are angiotensin II receptor antagonists.